Daniel Loeb's position in Amedisys is currently worth $28.8 Million. That's 0.48% of their equity portfolio (30th largest holding). Daniel Loeb acquired their 300 Thousand shares in Q1 2009. So far they never sold any shares in the company. The stake costed the investor $11.7 Million, netting the investor a gain of 147% so far.